Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 13;21(1):49.
doi: 10.1186/s12877-020-01861-9.

Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy

Affiliations

Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy

Shang Huang et al. BMC Geriatr. .

Abstract

Background: In bladder cancer patients with age ≥ 80 years old, there have been controversies in performing uretero-cutaneostomy or ileal conduit as urinary diversion after radical cystectomy. Limited study evaluated overall survival (OS) and cancer-specific survival (CSS) between the two urinary diversions in elderly patients. This study is to compare OS and CSS between uretero-cutaneostomy and ileal conduit after radical cystectomy in bladder cancer patients with age ≥ 80 years old.

Patients and methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Bladder cancer patients diagnosed between 2004 and 2016 with age ≥ 80 years old who underwent radical cystectomy with either UC or IC were selected. After propensity score matching, Cox regression and Kaplan-Meier analysis were used to analyze the survival. We calculated statistical power for survival.

Results: Of 1394 patients who met the inclusion criteria, 1093 underwent ileal conduit and 301 underwent uretero-cutaneostomy. After propensity score matching, 285 patients were included in each group. Multivariable Cox analysis showed urinary diversion was not a risk factor of OS and CSS (HR 1.044, [95% CI 0.867-1.257] and 1.012 [0.748-1.368], respectively). Both OS and CSS were not significantly different, with median survival of ileal conduit and uretero-cutaneostomy were 19 [16-24] months and 19 [15-26] months respectively. Additionally, We found OS had the following risk factors: tumor stage (distant vs regional vs localized, 5.332 [3.610-7.875] vs 1.730 [1.375-2.176] vs 1), node density (>0.2 vs ≤0.2 vs none, 1.410 [1.047-1.898] vs 0.941 [0.658-1.344] vs 1) and age (1.067 [1.032-1.103] for each year). While CSS had the following risk factors: tumor stage (distant vs regional vs localized, 4.035 [2.046-7.959] vs 2.476 [1.651-3.713] vs 1), node density (>0.2 vs ≤0.2 vs none, 2.501 [1.645-3.804] vs 1.062 [0.590-1.914] vs 1) and tumor size (greater than 3 cm vs less than 3 cm, 1.596 [1.057-2.412] vs 1). Our analysis obtained 0.707 power for overall survival.

Conclusion: Urinary diversion by uretero-cutaneostomy or by ileal conduit was not associated with overall and cancer-specific survival. It is reasonable to consider uretero-cutaneostomy as a regular procedure of urinary diversion in elderly bladder cancer patients after radical cystectomy to avoid associate complications.

Keywords: 80 and over; Aged; SEER program; Urinary bladder neoplasms; Urinary diversion.

PubMed Disclaimer

Conflict of interest statement

Shang Huang and Xuecheng Bi report grant from Health Commission of Guangdong Province, during the conduct of the study.

Figures

Fig. 1
Fig. 1
Kaplan-Meier curve of overall survival according to urinary diversion after propensity score matching. No significant difference is found between ileal conduit and uretero-cutaneostomy with median survival 19 months (95% CI 16–24) and 19 months (95% CI 15–26) respectively (p = 0.652). Survival is measured in months
Fig. 2
Fig. 2
Kaplan-Meier curve of cancer-specific survival according to urinary diversion after propensity score matching. No significant difference is found between ileal conduit and uretero-cutaneostomy (p = 0.936). Survival is measured in months
Fig. 3
Fig. 3
Power-effect curve of overall survival (a) and cancer-specific survival (b) with N = 570 and alpha = 0.05. Vertical dotted line indicates postulated hazard ratio of 1.257; Horizontal dotted line indicates the power; N = 570 because 285 patients are in each urinary diversion group

Comment in

  • Geriatrics.
    Griebling TL. Griebling TL. J Urol. 2021 Jun;205(6):1801-1804. doi: 10.1097/JU.0000000000001724. Epub 2021 Apr 1. J Urol. 2021. PMID: 33792370 No abstract available.

Similar articles

Cited by

References

    1. Weiner AB, Keeter MK, Manjunath A, Meeks JJ. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004–2013) Urol Oncol. 2018;36(237):e239–e237. - PubMed
    1. Nieuwenhuijzen JA, de Vries RR, Bex A, van der Poel HG, Meinhardt W, Antonini N, Horenblas S. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol. 2008;53:834–842. doi: 10.1016/j.eururo.2007.09.008. - DOI - PubMed
    1. Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol. 2013;63:67–80. doi: 10.1016/j.eururo.2012.08.050. - DOI - PubMed
    1. Vakalopoulos I, Dimitriadis G, Anastasiadis A, Gkotsos G, Radopoulos D. Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer? Int Urol Nephrol. 2011;43:743–748. doi: 10.1007/s11255-011-9904-2. - DOI - PubMed
    1. Nahar B, Koru-Sengul T, Miao F, Prakash NS, Venkatramani V, Gauri A, Alonzo D, Alameddine M, Swain S, Punnen S, et al. Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy. World J Urol. 2018;36:393–399. doi: 10.1007/s00345-017-2140-3. - DOI - PubMed

Publication types